These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31522376)

  • 21. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
    Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
    J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay.
    Borgfeldt C; Forslund O
    J Virol Methods; 2019 Aug; 270():18-20. PubMed ID: 31002831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    Drysdale H; Marlow LA; Lim A; Sasieni P; Waller J
    J Med Screen; 2022 Sep; 29(3):194-202. PubMed ID: 35389282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire.
    Drysdale H; Marlow LAV; Lim A; Waller J
    Health Expect; 2024 Aug; 27(4):e14118. PubMed ID: 38953514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
    Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
    BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial.
    Hellsten C; Ernstson A; Bodelsson G; Forslund O; Borgfeldt C
    Eur J Cancer Prev; 2021 Jul; 30(4):334-340. PubMed ID: 34010238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
    Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
    Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.
    Tranberg M; Petersen LK; Hammer A; Elfström M; Blaakær J; Jørgensen SF; Bennetsen MH; Jensen JS; Andersen B
    PLoS Med; 2023 Jul; 20(7):e1004253. PubMed ID: 37410699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
    Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
    J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening.
    Cadman L; Wilkes S; Mansour D; Austin J; Ashdown-Barr L; Edwards R; Kleeman M; Szarewski A
    J Med Screen; 2015 Mar; 22(1):28-37. PubMed ID: 25403717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of the BioPerfectus multiplex real time HPV assay for self-collected samples cervical cancer screening].
    Chen Q; Du H; Wang C; Hu QC; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):307-311. PubMed ID: 31154711
    [No Abstract]   [Full Text] [Related]  

  • 40. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study.
    Wikström I; Lindell M; Sanner K; Wilander E
    Br J Cancer; 2011 Jul; 105(3):337-9. PubMed ID: 21730977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.